Br Med J (Clin Res Ed)  1987;294:531-534 (28 February), doi:10.1136/bmj.294.6571.531

Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.

G A MacGregor, N D Markandu, D R Singer, F P Cappuccio, A C Shore, G A Sagnella

Fifteen unselected patients who had essential hypertension and whose average supine blood pressure when they were not receiving any treatment and their usual sodium intake was 162/107 mm Hg were treated with captopril 50 mg twice daily. After one month's treatment their supine blood pressure had decreased to 149/94 mm Hg. They were then instructed to reduce their sodium intake to about 80 mmol(mEq)/day. After two weeks of moderate sodium restriction they were entered into a double blind randomised crossover study comparing the effect of 10 Slow Sodium tablets (100 mmol sodium chloride) with matching placebo tablets while continuing to take captopril and restrict sodium in their diet. After one month of taking placebo their mean supine blood pressure was 137/88 mm Hg with a urinary sodium excretion of 83 mmol/24 h, while after one month of taking Slow Sodium tablets their mean supine blood pressure was 150/97 mm Hg (p less than 0.001) with a sodium excretion of 183 mmol/24 h. The mean supine blood pressure during moderate sodium restriction therefore decreased by 9% and correlated significantly with the reduction in urinary sodium excretion. These results suggest that the combination of treatment with a moderate but practical reduction in sodium intake and an angiotensin converting enzyme inhibitor is effective in decreasing the blood pressure in patients with essential hypertension. This combined approach overcomes some of the objections that have been made to salt restriction alone and to converting enzyme inhibitors alone.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Swift, P. A., Markandu, N. D., Sagnella, G. A., He, F. J., MacGregor, G. A. (2005). Modest Salt Reduction Reduces Blood Pressure and Urine Protein Excretion in Black Hypertensives: A Randomized Control Trial. Hypertension 46: 308-312 [Abstract] [Full text]  
  • Doulton, T. W., MacGregor, G. A (2004). Review: Blood pressure in haemodialysis patients: The importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume. Journal of Renin-Angiotensin-Aldosterone System 5: 14-22 [Abstract]  
  • He, F. J, MacGregor, G. A (2003). Review: Salt, blood pressure and the renin-angiotensin system. Journal of Renin-Angiotensin-Aldosterone System 4: 11-16 [Abstract]  
  • MacGregor, G. A, He, F. J, Perry, I. J, Law, M R, Wald, N J, Hooper, L., Bartlett, C., Davey Smith, G., Ebrahim, S. (2003). Long term effects of advice to reduce dietary salt. BMJ 326: 222-222 [Full text]  
  • He, F. J, MacGregor, G. A (2001). Salt -- The DASH-Sodium trial. Journal of Renin-Angiotensin-Aldosterone System 2: 93-95  
  • Graudal, N. A., Galloe, A. M., Garred, P. (1998). Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride: A Meta-analysis. JAMA 279: 1383-1391 [Abstract] [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ